Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
B 192.5 -3.18% -6.33
NVCR closed down 3.18 percent on Friday, April 16, 2021, on approximately normal volume.
Earnings due: Apr 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NVCR trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -3.18%
Upper Bollinger Band Walk Strength -3.18%
Multiple of Ten Bullish Other -3.18%
Wide Bands Range Expansion -3.18%
Above Upper BB Strength -3.18%
Older End-of-Day Signals for NVCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Classification

Keywords: Medicine Cancer Clinical Medicine Oncology Small Cell Lung Cancer Ovarian Cancer Non Small Cell Lung Cancer Tumor Blastoma Glioblastoma Pancreatic Cancer Aging Associated Diseases Helio Brain Cancer Brain Tumor European Union Solid Tumor Cancers Metastases Mesothelioma Brain Metastases

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 218.0
52 Week Low 55.4
Average Volume 1,109,332
200-Day Moving Average 126.13
50-Day Moving Average 153.27
20-Day Moving Average 144.25
10-Day Moving Average 156.81
Average True Range 12.74
ADX 35.74
+DI 48.52
-DI 9.98
Chandelier Exit (Long, 3 ATRs ) 179.79
Chandelier Exit (Short, 3 ATRs ) 157.81
Upper Bollinger Band 194.71
Lower Bollinger Band 93.78
Percent B (%b) 0.98
BandWidth 69.97
MACD Line 10.23
MACD Signal Line 1.52
MACD Histogram 8.7148
Fundamentals Value
Market Cap 19.6 Billion
Num Shares 102 Million
EPS 0.18
Price-to-Earnings (P/E) Ratio 1046.20
Price-to-Sales 27.48
Price-to-Book 38.68
PEG Ratio -0.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 206.17
Resistance 3 (R3) 205.91 201.09 203.89
Resistance 2 (R2) 201.09 197.61 201.22 203.13
Resistance 1 (R1) 196.80 195.46 194.39 197.06 202.37
Pivot Point 191.98 191.98 190.77 192.11 191.98
Support 1 (S1) 187.68 188.50 185.27 187.94 182.63
Support 2 (S2) 182.86 186.35 182.99 181.87
Support 3 (S3) 178.57 182.86 181.11
Support 4 (S4) 178.83